Scientific Advisory Committee
Reetta Kälviäinen obtained her MD and PhD at the University of Kuopio, Finland. Dr Kälviäinen acts as Head of the Outpatient Clinic at the Kuopio University Hospital as well as Docent of Clinical Neurology and Project Leader of Clinical Epilepsy Research at the Department of Neuroscience and Neurology at the Kuopio University.
She is a member of several associations and societies, which among others include President of the Finnish Epilepsy Association (Chapter of International Bureau for Epilepsy, IBE), Secretary of the Finnish Epilepsy Society (Chapter of International League Against Epilepsy, ILAE), Trustee in the Finnish Epilepsy Research Foundation and Chair of the Board of Trustees in the Vaajasalo Foundation supporting epilepsy research. She is a member of the ILAE Commission on Therapeutic Strategies and of the ILAE Subcommission on Antiepileptic Drug Guidelines.
Her special research interest is clinical epileptology including the prognostic factors of newly diagnosed epilepsy, the possible progressive nature of the epileptic process as well as cognitive functions and neuroimaging in epilepsy. These aspects of scientific projects are combined with therapeutic neuropharmacological interventions. She has participated in many multinational multi-center drug trials and has designed numerous single center studies performed at Kuopio University Hospital Epilepsy Center. Many of the drug trials have included evaluation of the cognitive effects of new anti-epileptic drugs. In addition, Dr Kälviäinen is an active participant in the epilepsy surgery program of the Kuopio University Hospital.
She is a member of several associations and societies, which among others include President of the Finnish Epilepsy Association (Chapter of International Bureau for Epilepsy, IBE), Secretary of the Finnish Epilepsy Society (Chapter of International League Against Epilepsy, ILAE), Trustee in the Finnish Epilepsy Research Foundation and Chair of the Board of Trustees in the Vaajasalo Foundation supporting epilepsy research. She is a member of the ILAE Commission on Therapeutic Strategies and of the ILAE Subcommission on Antiepileptic Drug Guidelines.
Her special research interest is clinical epileptology including the prognostic factors of newly diagnosed epilepsy, the possible progressive nature of the epileptic process as well as cognitive functions and neuroimaging in epilepsy. These aspects of scientific projects are combined with therapeutic neuropharmacological interventions. She has participated in many multinational multi-center drug trials and has designed numerous single center studies performed at Kuopio University Hospital Epilepsy Center. Many of the drug trials have included evaluation of the cognitive effects of new anti-epileptic drugs. In addition, Dr Kälviäinen is an active participant in the epilepsy surgery program of the Kuopio University Hospital.

